Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Australia considers imposing windfall tax on liquefied natural gas

Australia considers imposing windfall tax on liquefied natural gas

金十金十2026/03/20 05:02
Show original
Golden Ten Data reported on March 20 that, in order to take advantage of the surge in fuel prices, Australian Prime Minister Albanese has asked the Treasury to study the imposition of a windfall tax on the massive liquefied natural gas industry. Energy Minister Chris Bowen confirmed this at a press conference on Friday, but did not provide further details. Australia was the world's third-largest exporter of liquefied natural gas last year, exporting nearly 80 million tons worth 65 billion Australian dollars (46 billion US dollars) in the year ending June 2025, mainly to Japan, South Korea, and China. According to the industry lobbying group "Australian Energy Producers," the oil and gas industry paid about 22 billion Australian dollars in taxes and royalties during 2024-2025. The group warned that increasing taxes would hinder investment in new gas supplies, lead to shortages in the domestic market, and cause pain for households at a time when inflation is already high. The group's CEO, Samantha McCulloch, stated that imposing a windfall tax would make Australia more vulnerable to future energy shocks.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium, as the issue price drops to the lower limit of $14.

Early-stage biotechnology company TRex Bio has priced its IPO at the lower end of the range at $14 per share, raising $116.7 million and achieving a market capitalization of $384 million. The company will be listed on Nasdaq on Friday, with Eli Lilly expressing interest in increasing its stake.

智通财经•2026/10/09 07:09

Small molecule biotechnology company Iambic Therapeutics (IAM.US) IPO priced at $15-17 per share, aiming to raise $150 millions.

Iambic Therapeutics plans to raise $150 millions by issuing 9.4 million shares, with an offering price range of $15 to $17 per share.

智通财经•2026/10/09 07:08

Pimco warns: 10-year US Treasury yield may hit 6%, for the first time since 2000

PIMCO's Chief Investment Officer stated that due to high oil prices intensifying inflation concerns and market unease over the growing U.S. public debt, the benchmark 10-year U.S. Treasury yield could rise to 6% for the first time since 2000.

智通财经•2026/10/09 06:47